|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
About the Cover for Blood 114 (10)
A highly F18-FDG-avid focal myeloma lesion (top image) resolved on follow-up PET-CT examination after 2 cycles of induction therapy (bottom image). When systematically examined as part of Total Therapy 3, such PET-CR status achieved prior to first transplantation was a prognostic indicator of reduced risk of relapse by 49% and of death by 59%, independent of risk as defined by gene array analysis. See the article by Bartel et al on page 2068. [Table of Contents] |
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
